Dristan Spray
NDC Package 80070-400-05
Package Information
Dristan (oxymetazoline hydrochloride) sprays is adults and children 6 to under 12 years of age (with adult supervision): 2 to 3 sprays in each nostril not more often than every 10 to 12 hours. This formulation utilizes a spray delivery system. Marketed by Foundation Consumer Brands, this product is identified by NDC 80070-400 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1000990 - oxymetazoline HCl 0.05 % Nasal Spray
- RxCUI: 1000990 - oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray
- RxCUI: 1000990 - oxymetazoline hydrochloride 0.05 % Nasal Spray
- RxCUI: 1000996 - Dristan 12-Hour 0.05 % Nasal Spray
- RxCUI: 1000996 - oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Dristan 12-Hour Nasal Spray]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 80070 - Foundation Consumer Brands
- 80070-400 - Dristan
- 80070-400-05 - 1 BOTTLE, SPRAY in 1 CARTON / 15 mL in 1 BOTTLE, SPRAY
- 80070-400 - Dristan
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (80070-400). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 80070-400-05 identifies a specific commercial package of 1 bottle, spray in 1 carton / 15 ml in 1 bottle, spray of Dristan 12 Hr, a human over the counter drug labeled by Foundation Consumer Brands. This spray is formulated for nasal use and contains oxymetazoline hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Foundation Consumer Brands on August 17, 2021. The current certification is valid through December 31, 2026.
How is this Foundation Consumer Brands product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 80070040005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.